Get the Stockscreener App
0.54
0.93%
0.005
After Hours:
.52
-0.02
-3.70%
Nexgel Inc stock is traded at $0.54, with a volume of 81,245.
It is up +0.93% in the last 24 hours and down -16.54% over the past month.
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
See More
Previous Close:
$0.535
Open:
$0.5351
24h Volume:
81,245
Relative Volume:
0.22
Market Cap:
$4.93M
Revenue:
$11.42M
Net Income/Loss:
$-2.89M
P/E Ratio:
-1.4173
EPS:
-0.381
Net Cash Flow:
$-1.38M
1W Performance:
+5.88%
1M Performance:
-16.54%
6M Performance:
-66.87%
1Y Performance:
-76.00%
1-Day Range:
$0.532
$0.5799
1-Week Range:
$0.4967
$0.649
52-Week Range:
$0.4811
$2.8899
Nexgel Inc Stock (NXGL) Company Profile
Name
Nexgel Inc
Sector
Industry
Phone
215 702-8550
Address
2150 CABOT BLVD WEST,, LANGHORNE
Compare NXGL vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NXGL
Nexgel Inc
|
0.54 | 4.89M | 11.42M | -2.89M | -1.38M | -0.381 |
ISRG
Intuitive Surgical Inc
|
438.10 | 155.76B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.63 | 40.30B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.78 | 33.13B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.01 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
208.05 | 30.31B | 5.54B | 1.52B | 1.74B | 10.37 |
Nexgel Inc Stock (NXGL) Latest News
Langhorne’s Nexgel transforms near disaster into ‘three-team trade’ acquisition - MSN
NXGL Should I Buy - Intellectia AI
NXGL SEC FilingsNexgel Inc 10-K, 10-Q, 8-K Forms - Stock Titan
NXGL Stock Price, Quote & Chart | NEXGEL INC (NASDAQ:NXGL) - ChartMill
Maxim Group Maintains NexGel(NXGL.US) With Buy Rating, Maintains Target Price $2 - Moomoo
NexGel Inc stock (US65340W1027): clinical laser study puts hydrogel specialist in focus - AD HOC NEWS
Nexgel hydrogel patch reduces laser plume in hair removal study By Investing.com - Investing.com South Africa
Nexgel hydrogel patch reduces laser plume in hair removal study - Investing.com
New laser hair removal patch cuts carcinogenic plume, eases pain in study - Stock Titan
Director boosts NEXGEL (NXGL) exposure with convertible note and warrant - Stock Titan
NEXGEL (NXGL) director buys $1M convertible note and stock warrant - Stock Titan
NEXGEL (NXGL) CEO acquires convertible note and 50,000-share stock warrant - Stock Titan
NEXGEL (NXGL) director Harris Kevin McClain listed on Form 3 - Stock Titan
NEXGEL (NASDAQ: NXGL) director lists warrant and note positions - Stock Titan
NexGel Inc stock (US65340W1027): Q1 2026 numbers put hydrogel growth story in focus - AD HOC NEWS
NEXGEL, Inc. (NASDAQ:NXGL) Q1 2026 Earnings Call Transcript - Insider Monkey
Nexgel Earnings Call: BioNX Bet Amid Cash Strain - TipRanks
NexGel Raises Insider-Funded Convertible Notes to Bolster Liquidity - TipRanks
NEXGEL Adds Sequence Executives to Board After Deal Financing - MyChesCo
NexGel Raises $1.21 Million Via Convertible Notes and Warrants; $0.60 Conversion, $0.80 Exercise - TradingView
NexGel (NASDAQ: NXGL) sells $1.21M in convertible notes with warrants - Stock Titan
Nexgel (NXGL) Q1 2026 Earnings Transcript - The Globe and Mail
NXGL: BioNX acquisition set to triple annual revenue and drive immediate profitability - TradingView
Earnings call transcript: Nexgel Q1 2026 reveals revenue decline, stock dips - Investing.com India
NXGL: BioNX acquisition set to triple revenue and drive profitability as legacy business stabilizes - TradingView
NexGel Q1 2026 Earnings Call Transcript - Benzinga
Nexgel Inc reports results for the quarter ended March 31Earnings Summary - TradingView
NXGL: Q1 2026 saw revenue down 5.6%, a $927K net loss, and a major acquisition funded by new capital - TradingView
NEXGEL, INC. 1Q 2026: Revenue $2.65M, EPS $(0.11) — 10-Q Summary - TradingView
NexGel (NASDAQ: NXGL) posts Q1 2026 loss and flags going concern risks amid new debt - Stock Titan
NEXGEL, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
NexGel Inc (NXGLW) Stock: Consolidating at $$0.05 — Next Move Ahead 2026-05-14Sector Leader - newser.com
Nexgel appoints Dave Hazard as VP of sales for BIONX Surgical By Investing.com - Investing.com India
NEXGEL, Inc. announced that it has received $1.21 million in funding - marketscreener.com
TradingKey - tradingkey.com
Nexgel appoints Dave Hazard as VP of sales for BIONX Surgical - Investing.com Australia
Nexgel appoints Dave Hazard as vice president of sales for Bionx Surgical - marketscreener.com
NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical - GlobeNewswire
Nexgel Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
NEXGEL Strengthens Board with Sequence LifeScience Leaders - TipRanks
Sequence execs join NEXGEL (NASDAQ: NXGL) board after $5.5M note deal - Stock Titan
Earnings Preview: NexGel to Report Financial Results Pre-market on May 15 - 富途牛牛
NEXGEL To Report First Quarter 2026 Financial Results on May 15th - The Manila Times
NEXGEL, Inc. to Announce First Quarter 2026 Financial Results on May 15, 2026, with Conference Call Scheduled for 12:00 P.M. ET - Quiver Quantitative
NEXGEL, Inc. announced that it expects to receive $1.21 million in funding - marketscreener.com
NEXGEL, Inc. announced that it has received $1 million in funding - marketscreener.com
NexGel (NXGL) Eps Diluted (TTM) - Zacks Investment Research
NXGLW NexGel Inc warrant holders await quarterly earnings details as report data remains unavailable, stock movement muted today.Credit Risk - newser.com
NEXGEL (NXGL) CFO details warrants, convertible note and 160,000-share option - Stock Titan
Sequence LifeScience, Inc. announced that it has received $5.5 million in funding from NEXGEL, Inc. - marketscreener.com
After $5.5M deal backing, Sequence executives take 2 NEXGEL board seats - Stock Titan
Nexgel Inc Stock (NXGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):